Drugs / Hepatitis B recombinant DNA vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03149874 Comparator | Dec 2014 → Apr 2017 | hepatitis B virus infection | Benha University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatitis B recombinant DNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03149874 ↗ |
| Modality | Vaccine | “Hepatitis B recombinant DNA vaccine” NCT03149874 ↗ |
| Route | Intramuscular | “intramuscularly injected” NCT03149874 ↗ |